{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:47:13Z","timestamp":1787932033346,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jaci.2013.05.036","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T20:15:16Z","timestamp":1374783316000},"page":"1184-1193.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Infliximab induces downregulation of the IL-12\/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages"],"prefix":"10.1016","volume":"132","author":[{"given":"Patrick M.","family":"Brunner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Koszik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"Reininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine L.","family":"Kalb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.05.036_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis\u2014epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.05.036_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2013.05.036_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2013.05.036_bib5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaci.2010.12.009","article-title":"Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17\/TH1 T-cell responses","volume":"127","author":"H\u00e4nsel","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.05.036_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2011.10583.x","article-title":"Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials","volume":"166","author":"Reich","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","article-title":"A novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF","volume":"53","author":"Kriegler","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2013.05.036_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaci.2013.05.036_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s004030050317","article-title":"Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis","volume":"290","author":"Ackermann","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2013.05.036_bib12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"Austin","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib13","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4049\/jimmunol.176.3.1431","article-title":"Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2","volume":"176","author":"Johansen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.05.036_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1993.tb03457.x","article-title":"Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor","volume":"94","author":"Kristensen","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2013.05.036_bib15","first-page":"129","article-title":"Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis","volume":"138","author":"Nickoloff","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2013.05.036_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s004030050299","article-title":"An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis","volume":"290","author":"Terajima","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2013.05.036_bib17","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.05.036_bib18","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/jid.2010.165","article-title":"A subpopulation of CD163-positive macrophages is classically activated in psoriasis","volume":"130","author":"Fuentes-Duculan","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2013.05.036_bib20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.23447","article-title":"Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab","volume":"58","author":"Mitoma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2013.05.036_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1097-0029(20000801)50:3<243::AID-JEMT8>3.0.CO;2-B","article-title":"Detection of membrane-bound tumor necrosis factor (TNF): an analysis of TNF-specific reagents","volume":"50","author":"Gerspach","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.jaci.2013.05.036_bib22","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI32282","article-title":"Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages","volume":"117","author":"Zaba","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.05.036_bib23","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","article-title":"Characterization of human blood dendritic cell subsets","volume":"100","author":"MacDonald","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.05.036_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(02)00393-X","article-title":"6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells","volume":"17","author":"Sch\u00e4kel","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.05.036_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.05.036_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: implications for health and disease","volume":"53","author":"Wong","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaci.2013.05.036_bib27","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.05.036_bib28","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets","volume":"118","author":"Wong","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.05.036_bib29","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1182\/blood-2011-01-326827","article-title":"SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset","volume":"118","author":"Zawada","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.05.036_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.immuni.2006.03.020","article-title":"Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes","volume":"24","author":"Sch\u00e4kel","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.05.036_bib31","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1182\/blood-2012-08-447045","article-title":"FcgammaRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens","volume":"121","author":"D\u00f6bel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.05.036_bib32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/44.12.8985127","article-title":"Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining","volume":"44","author":"Hunyady","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jaci.2013.05.036_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2230.2011.04213.x","article-title":"Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation","volume":"37","author":"G\u00fcnther","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s004030100214","article-title":"Tumor\u00a0necrosis factor alpha (TNFalpha) in human skin: a comparison of different antibodies for immunohistochemistry","volume":"293","author":"van der Laan","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2013.05.036_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2009.01.002","article-title":"Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor","volume":"131","author":"Kaymakcalan","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2013.05.036_bib36","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4","article-title":"A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in\u00a0vitro priming of cytotoxic T lymphocytes","volume":"28","author":"Sch\u00e4kel","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2013.05.036_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.33418","article-title":"The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population","volume":"64","author":"Rossol","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2013.05.036_bib38","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaci.2013.05.036_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cyto.2008.11.008","article-title":"Differences in binding and effector functions between classes of TNF antagonists","volume":"45","author":"Arora","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2013.05.036_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.05.036_bib41","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in\u00a0vitro and in\u00a0vivo: implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2013.05.036_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.05.036_bib43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.05.036_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.05.036_bibE1","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2353\/ajpath.2010.100277","article-title":"Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-\/IL-17-producing CD8+ T cells?","volume":"177","author":"Stary","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2013.05.036_bibE2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/44.12.8985127","article-title":"Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining","volume":"44","author":"Hunyady","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jaci.2013.05.036_bibE3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000321711","article-title":"Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial","volume":"222","author":"Bangert","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2013.05.036_bibE4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.4049\/jimmunol.1102437","article-title":"TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in\u00a0vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity","volume":"188","author":"Kalb","year":"2012","journal-title":"J Immunol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2013.05.036_bibE5","doi-asserted-by":"crossref","first-page":"ii65","DOI":"10.1136\/ard.2004.031237","article-title":"Psoriasis assessment tools in clinical trials","volume":"64","author":"Feldman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2013.05.036_bibE6","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2006-10-053280","article-title":"Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment","volume":"109","author":"Amatschek","year":"2007","journal-title":"Blood"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913009159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913009159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:41:22Z","timestamp":1758789682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913009159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0091674913009159"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.05.036","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718050373.793517125","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab induces downregulation of the IL-12\/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}